BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34083661)

  • 1. Lung microbiome alterations in NSCLC patients.
    Zheng L; Sun R; Zhu Y; Li Z; She X; Jian X; Yu F; Deng X; Sai B; Wang L; Zhou W; Wu M; Li G; Tang J; Jia W; Xiang J
    Sci Rep; 2021 Jun; 11(1):11736. PubMed ID: 34083661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of the Human Lung and Gut Microbiomes in Non-Small Cell Lung Carcinomas and Distant Metastasis.
    Lu H; Gao NL; Tong F; Wang J; Li H; Zhang R; Ma H; Yang N; Zhang Y; Wang Y; Liang Z; Zeng H; Chen WH; Dong X
    Microbiol Spectr; 2021 Dec; 9(3):e0080221. PubMed ID: 34787462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysbiosis of lower respiratory tract microbiome are associated with inflammation and microbial function variety.
    Li KJ; Chen ZL; Huang Y; Zhang R; Luan XQ; Lei TT; Chen L
    Respir Res; 2019 Dec; 20(1):272. PubMed ID: 31796027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Gut Dysbiosis on the Risk of Non-Small-Cell Lung Cancer.
    Wei YF; Huang MS; Huang CH; Yeh YT; Hung CH
    Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36498063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Implications of the Lung Microbiota in Patients with Chronic Obstruction Pulmonary Disease and Non-Small Cell Lung Cancer.
    He JQ; Chen Q; Wu SJ; Wang DQ; Zhang SY; Zhang SZ; Chen RL; Wang JF; Wang Z; Yu CH
    Front Cell Infect Microbiol; 2022; 12():937864. PubMed ID: 35967848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of microbiota in saliva, bronchoalveolar lavage fluid, non-malignant, peritumoural and tumour tissue in non-small cell lung cancer patients: a cross-sectional clinical trial.
    Bingula R; Filaire E; Molnar I; Delmas E; Berthon JY; Vasson MP; Bernalier-Donadille A; Filaire M
    Respir Res; 2020 May; 21(1):129. PubMed ID: 32450847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysbiosis of lower respiratory tract microbiome are associated with proinflammatory states in non-small cell lung cancer patients.
    Li Y; Rao G; Zhu G; Cheng C; Yuan L; Li C; Gao J; Tang J; Wang Z; Li W
    Thorac Cancer; 2024 Jan; 15(2):111-121. PubMed ID: 38041547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of lower respiratory tract microbiome and short-chain fatty acids in different segments in lung cancer: a multiomics analysis.
    Zhang Y; Chen X; Wang Y; Li L; Ju Q; Zhang Y; Xi H; Wang F; Qiu D; Liu X; Chang N; Zhang W; Zhang C; Wang K; Li L; Zhang J
    Front Cell Infect Microbiol; 2023; 13():1261284. PubMed ID: 37915846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower airway bacterial microbiome may influence recurrence after resection of early-stage non-small cell lung cancer.
    Patnaik SK; Cortes EG; Kannisto ED; Punnanitinont A; Dhillon SS; Liu S; Yendamuri S
    J Thorac Cardiovasc Surg; 2021 Feb; 161(2):419-429.e16. PubMed ID: 32340803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjusting for age improves identification of gut microbiome alterations in multiple diseases.
    Ghosh TS; Das M; Jeffery IB; O'Toole PW
    Elife; 2020 Mar; 9():. PubMed ID: 32159510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upper versus lower airway microbiome and metagenome in children with cystic fibrosis and their correlation with lung inflammation.
    Kirst ME; Baker D; Li E; Abu-Hasan M; Wang GP
    PLoS One; 2019; 14(9):e0222323. PubMed ID: 31536536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diminishing microbiome richness and distinction in the lower respiratory tract of lung cancer patients: A multiple comparative study design with independent validation.
    Jin J; Gan Y; Liu H; Wang Z; Yuan J; Deng T; Zhou Y; Zhu Y; Zhu H; Yang S; Shen W; Xie D; Wu H; Liu D; Li W
    Lung Cancer; 2019 Oct; 136():129-135. PubMed ID: 31494531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the composition of the upper respiratory tract microbial community in granulomatosis with polyangiitis.
    Lamprecht P; Fischer N; Huang J; Burkhardt L; Lütgehetmann M; Arndt F; Rolfs I; Kerstein A; Iking-Konert C; Laudien M
    J Autoimmun; 2019 Feb; 97():29-39. PubMed ID: 30420263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Preliminary Study of Microbiota Diversity in Saliva and Bronchoalveolar Lavage Fluid from Patients with Primary Bronchogenic Carcinoma.
    Wang K; Huang Y; Zhang Z; Liao J; Ding Y; Fang X; Liu L; Luo J; Kong J
    Med Sci Monit; 2019 Apr; 25():2819-2834. PubMed ID: 30994108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shared gut, but distinct oral microbiota composition in primary Sjögren's syndrome and systemic lupus erythematosus.
    van der Meulen TA; Harmsen HJM; Vila AV; Kurilshikov A; Liefers SC; Zhernakova A; Fu J; Wijmenga C; Weersma RK; de Leeuw K; Bootsma H; Spijkervet FKL; Vissink A; Kroese FGM
    J Autoimmun; 2019 Feb; 97():77-87. PubMed ID: 30416033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metagenomic analysis of the lung microbiome in pulmonary tuberculosis - a pilot study.
    Hu Y; Cheng M; Liu B; Dong J; Sun L; Yang J; Yang F; Chen X; Jin Q
    Emerg Microbes Infect; 2020 Dec; 9(1):1444-1452. PubMed ID: 32552447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Alterations of Vaginal Microbiome in HPV16 Infection as Identified by Shotgun Metagenomic Sequencing.
    Yang Q; Wang Y; Wei X; Zhu J; Wang X; Xie X; Lu W
    Front Cell Infect Microbiol; 2020; 10():286. PubMed ID: 32656096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symbiotic microbial communities in various locations of the lung cancer respiratory tract along with potential host immunological processes affected.
    Cheng J; Zhou L; Wang H
    Front Cell Infect Microbiol; 2024; 14():1296295. PubMed ID: 38371298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary Microbial Dysbiosis is Associated with Systemic Inflammatory Markers and Predicted Oral Metabolites in Non-Small Cell Lung Cancer Patients.
    Zhang W; Luo J; Dong X; Zhao S; Hao Y; Peng C; Shi H; Zhou Y; Shan L; Sun Q; Li Y; Zhao X
    J Cancer; 2019; 10(7):1651-1662. PubMed ID: 31205521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysbiosis of the Gut Microbiome in Lung Cancer.
    Zhuang H; Cheng L; Wang Y; Zhang YK; Zhao MF; Liang GD; Zhang MC; Li YG; Zhao JB; Gao YN; Zhou YJ; Liu SL
    Front Cell Infect Microbiol; 2019; 9():112. PubMed ID: 31065547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.